Inventor · disambiguated record
Dwight D. Koeberl
Also filed as: KOEBERL DWIGHT · KOEBERL DWIGHT D
18 granted patents·10 pending applications·143 citations·filing 2002–2024
94Inventor score
Top patents by PatentIndex Score
28 records- 0195US10098905B2Immunomodulating gene therapyUNIV DUKE·Filed 2015·Granted Oct 16, 2018·10 cites·7 claims
- 0295US9186420B2Immunomodulating gene therapyKOEBERL DWIGHT D·Filed 2010·Granted Nov 17, 2015·26 cites·5 claims
- 0392US11690812B2Methods and compositions for the treatment of steatosis-associated disordersUNIV DUKE·Filed 2021·Granted Jul 4, 2023·3 cites·19 claims
- 0492US11547717B2Immunomodulating gene therapyUNIV DUKE·Filed 2018·Granted Jan 10, 2023·4 cites·7 claims
- 0592US7858367B2Viral vectors and methods for producing and using the sameUNIV DUKE·Filed 2003·Granted Dec 28, 2010·41 cites·58 claims
- 0691US10869906B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2017·Granted Dec 22, 2020·4 cites·17 claims
- 0790US10940125B2Methods and compositions for the treatment of steatosis-associated disordersUNIV DUKE·Filed 2016·Granted Mar 9, 2021·6 cites·10 claims
- 0890US9873868B2Constructs for expressing lysosomal polypeptidesKOEBERL DWIGHT D·Filed 2012·Granted Jan 23, 2018·10 cites·11 claims
- 0989US11421211B2Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2017·Granted Aug 23, 2022·4 cites·9 claims
- 1089US8679478B2Methods of lysosomal storage disease therapyKOEBERL DWIGHT D·Filed 2011·Granted Mar 25, 2014·7 cites·17 claims
- 1188US12036190B2Methods and compositions for the treatment of cytoplasmic glycogen storage disordersUNIV DUKE·Filed 2021·Granted Jul 16, 2024·1 cites·14 claims
- 1288US9592247B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2014·Granted Mar 14, 2017·9 cites·14 claims
- 1385US10028993B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2017·Granted Jul 24, 2018·4 cites·14 claims
- 1484US2024398729A1Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage DisordersUNIV DUKE·Filed 2024·Application pending·0 cites
- 1582US12171731B2Methods and compositions for the treatment of steatosis-associated disordersUNIV DUKE·Filed 2023·Granted Dec 24, 2024·0 cites·17 claims
- 1681US8809282B2Method of reducing titers of antibodies specific for a therapeutic agentKISHNANI PRIYA S·Filed 2011·Granted Aug 19, 2014·7 cites·8 claims
- 1779US2023210884A1Immunomodulating Gene TherapyUNIV DUKE·Filed 2022·Application pending·0 cites
- 1877US11717560B2Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseasesUNIV DUKE·Filed 2021·Granted Aug 8, 2023·1 cites·17 claims
- 1975US6946126B2Replicating adenovirus vectorsUNIV DUKE·Filed 2002·Granted Sep 20, 2005·6 cites·70 claims
- 2073US12290549B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2020·Granted May 6, 2025·0 cites·16 claims
- 2169US2025205367A1Compositions comprising a muscle active promoter and methods of using the sameUNIV DUKE·Filed 2024·Application pending·0 cites
- 2266US2024368587A1Compositions For and Methods of Editing the GenomeUNIV DUKE·Filed 2022·Application pending·0 cites
- 2365US2022389399A1Acid-alpha glucosidase variants and uses thereofGENETHON·Filed 2022·Application pending·0 cites
- 2464US2025376698A1Compositions and methods for promoting liver regeneration by gene editing in metabolic liver diseaseUNIV DUKE·Filed 2023·Application pending·0 cites
- 2561US2004248262A1Constructs for expressing lysomal polypeptidesFiled 2004·Application pending·0 cites
- 2660US2018371440A1Constructs for expressing lysosomal polypeptidesUNIV DUKE·Filed 2018·Application pending·0 cites
- 2752US2011294193A1Viral vectors and methods for producing and using the sameAMALFITANO ANDREA·Filed 2010·Application pending·0 cites
- 2842US2018326021A1Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage DisordersUNIV DUKE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dwight D. Koeberl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →